CM
RVMDW icon

Caption Management’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

Caption Management’s Portfolio RVMDW Stock Details RVMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.86M Hold
517,685
– – 0.02% 590
2026
Q1 		$927K Buy
517,685
+417,685
+418% +$809K 0.01% 1045
2025
Q4 		$94K Buy
+100,000
New +$56.4K ﹤0.01% 1444

Other funds holding RVMDW

LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Caption Management's RVMDW Position: Q2 2026 in Review

Caption Management held its Revolution Medicines Inc Warrant (RVMDW) position steady in Q2 2026 at 517,685 shares worth $4.86M. The position accounts for 0.02% of the portfolio, ranked #590.

Caption Management first reported a position in RVMDW in Q4 2025 and has held it in 3 quarters since. 22 funds tracked by Wall St. Rank hold RVMDW as of Q2 2026.

  • Caption Management held 517,685 shares of Revolution Medicines Inc Warrant worth $4.86M as of Q2 2026.
  • Caption Management left its Revolution Medicines Inc Warrant share count unchanged in Q2 2026.
  • Revolution Medicines Inc Warrant made up 0.02% of Caption Management's portfolio in Q2 2026, its #590 holding.
  • Caption Management first reported a position in Revolution Medicines Inc Warrant in Q4 2025 and has held it in 3 quarters since.
  • 22 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.